PFE logo

Pfizer (PFE) Gross profit

Annual gross profit:

$45.78B+$12.23B(+36.47%)
December 1, 2024

Summary

  • As of today (April 15, 2025), PFE annual gross profit is $45.78 billion, with the most recent change of +$12.23 billion (+36.47%) on December 1, 2024.
  • During the last 3 years, PFE annual gross profit has fallen by -$4.69 billion (-9.30%).
  • PFE annual gross profit is now -30.63% below its all-time high of $65.99 billion, reached on December 31, 2022.

Performance

PFE Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

quarterly gross profit:

$11.86B-$583.00M(-4.69%)
December 1, 2024

Summary

  • As of today (April 15, 2025), PFE quarterly gross profit is $11.86 billion, with the most recent change of -$583.00 million (-4.69%) on December 1, 2024.
  • Over the past year, PFE quarterly gross profit has stayed the same.
  • PFE quarterly gross profit is now -37.91% below its all-time high of $19.09 billion, reached on June 1, 2022.

Performance

PFE quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

TTM gross profit:

$45.77B+$4.85B(+11.85%)
December 1, 2024

Summary

  • As of today (April 15, 2025), PFE TTM gross profit is $45.77 billion, with the most recent change of +$4.85 billion (+11.85%) on December 1, 2024.
  • Over the past year, PFE TTM gross profit has stayed the same.
  • PFE TTM gross profit is now -31.51% below its all-time high of $66.83 billion, reached on December 31, 2022.

Performance

PFE TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPFEincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

PFE Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+36.5%0.0%0.0%
3 y3 years-9.3%0.0%0.0%
5 y5 years+39.3%0.0%0.0%

PFE Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-30.6%+36.5%-37.9%+180.7%-31.5%+40.9%
5 y5-year-30.6%+39.3%-37.9%+180.7%-31.5%+77.1%
alltimeall time-30.6%+1762.7%-37.9%+3376.5%-31.5%+4309.9%

Pfizer Gross profit History

DateAnnualQuarterlyTTM
Dec 2024
$45.78B(+36.5%)
$11.86B(-4.7%)
$45.77B(+11.8%)
Sep 2024
-
$12.44B(+24.6%)
$40.93B(+25.1%)
Jun 2024
-
$9.98B(-13.2%)
$32.71B(+0.7%)
Mar 2024
-
$11.50B(+64.1%)
$32.50B(-6.1%)
Dec 2023
$33.54B(-49.2%)
$7.01B(+65.9%)
$34.60B(-19.7%)
Sep 2023
-
$4.22B(-56.8%)
$43.08B(-22.3%)
Jun 2023
-
$9.77B(-28.2%)
$55.43B(-14.4%)
Mar 2023
-
$13.60B(-12.2%)
$64.75B(-3.1%)
Dec 2022
$65.99B(+30.8%)
$15.49B(-6.6%)
$66.83B(+2.1%)
Sep 2022
-
$16.57B(-13.2%)
$65.45B(+3.9%)
Jun 2022
-
$19.09B(+21.8%)
$62.98B(+12.9%)
Mar 2022
-
$15.68B(+11.2%)
$55.78B(+10.5%)
Dec 2021
$50.47B(+52.2%)
$14.10B(-0.0%)
$50.47B(+11.9%)
Sep 2021
-
$14.10B(+18.5%)
$45.08B(+14.9%)
Jun 2021
-
$11.90B(+14.9%)
$39.25B(+10.9%)
Mar 2021
-
$10.36B(+18.9%)
$35.38B(+6.7%)
Dec 2020
$33.17B(+1.0%)
$8.72B(+5.4%)
$33.17B(+28.3%)
Sep 2020
-
$8.27B(+2.9%)
$25.85B(-6.5%)
Jun 2020
-
$8.04B(-1.3%)
$27.66B(-8.7%)
Mar 2020
-
$8.14B(+481.6%)
$30.31B(-7.7%)
Dec 2019
$32.85B(+3.2%)
$1.40B(-86.1%)
$32.85B(+3.3%)
Sep 2019
-
$10.08B(-5.7%)
$31.79B(-1.6%)
Jun 2019
-
$10.69B(+0.0%)
$32.32B(+0.4%)
Mar 2019
-
$10.69B(+3033.4%)
$32.18B(+1.1%)
Dec 2018
$31.84B(-22.9%)
$341.00M(-96.8%)
$31.84B(-24.1%)
Sep 2018
-
$10.60B(+0.5%)
$41.94B(+0.7%)
Jun 2018
-
$10.55B(+2.0%)
$41.66B(+0.8%)
Mar 2018
-
$10.34B(-1.0%)
$41.35B(+0.1%)
Dec 2017
$41.32B(+2.0%)
$10.45B(+1.2%)
$41.32B(+0.1%)
Sep 2017
-
$10.32B(+0.9%)
$41.29B(+0.9%)
Jun 2017
-
$10.24B(-0.7%)
$40.92B(+0.6%)
Mar 2017
-
$10.31B(-1.0%)
$40.66B(+0.4%)
Dec 2016
$40.50B(+3.3%)
$10.42B(+4.6%)
$40.50B(-0.5%)
Sep 2016
-
$9.96B(-0.1%)
$40.72B(+0.2%)
Jun 2016
-
$9.97B(-1.8%)
$40.63B(+0.7%)
Mar 2016
-
$10.15B(-4.5%)
$40.33B(+2.9%)
Dec 2015
$39.20B(-2.1%)
$10.64B(+7.8%)
$39.20B(+0.6%)
Sep 2015
-
$9.87B(+2.0%)
$38.98B(-0.3%)
Jun 2015
-
$9.67B(+7.2%)
$39.11B(-1.6%)
Mar 2015
-
$9.03B(-13.3%)
$39.75B(-0.7%)
Dec 2014
$40.03B(-4.7%)
$10.42B(+4.2%)
$40.03B(-0.9%)
Sep 2014
-
$9.99B(-3.1%)
$40.38B(-0.9%)
Jun 2014
-
$10.31B(+10.8%)
$40.74B(-1.0%)
Mar 2014
-
$9.31B(-13.5%)
$41.16B(-2.0%)
Dec 2013
$42.00B(-6.3%)
$10.76B(+3.9%)
$42.00B(-0.9%)
Sep 2013
-
$10.36B(-3.5%)
$42.37B(-0.7%)
Jun 2013
-
$10.73B(+5.8%)
$42.66B(-2.0%)
Mar 2013
-
$10.15B(-8.9%)
$43.52B(-4.4%)
Dec 2012
$44.84B(-7.6%)
$11.14B(+4.6%)
$45.51B(+2.9%)
Sep 2012
-
$10.64B(-8.2%)
$44.24B(-5.5%)
Jun 2012
-
$11.59B(-4.5%)
$46.80B(-2.7%)
Mar 2012
-
$12.14B(+23.0%)
$48.12B(-1.4%)
Dec 2011
$48.53B(-3.7%)
$9.87B(-25.3%)
$48.79B(-4.8%)
Sep 2011
-
$13.20B(+2.2%)
$51.27B(+2.0%)
Jun 2011
-
$12.91B(+0.8%)
$50.28B(-1.1%)
Mar 2011
-
$12.81B(+3.7%)
$50.81B(+0.9%)
Dec 2010
$50.38B(+22.5%)
$12.35B(+1.2%)
$50.38B(-0.5%)
Sep 2010
-
$12.21B(-9.2%)
$50.63B(+4.9%)
Jun 2010
-
$13.45B(+8.7%)
$48.26B(+9.6%)
Mar 2010
-
$12.37B(-1.8%)
$44.04B(+7.1%)
Dec 2009
$41.12B(+2.3%)
$12.60B(+28.2%)
$41.12B(+5.0%)
Sep 2009
-
$9.83B(+6.5%)
$39.15B(-0.0%)
Jun 2009
-
$9.23B(-2.4%)
$39.17B(-1.5%)
Mar 2009
-
$9.46B(-11.0%)
$39.78B(-1.0%)
Dec 2008
$40.18B(+8.1%)
$10.63B(+7.9%)
$40.18B(+1.0%)
Sep 2008
-
$9.85B(+0.1%)
$39.80B(+6.6%)
Jun 2008
-
$9.84B(-0.2%)
$37.32B(+2.4%)
Mar 2008
-
$9.86B(-3.7%)
$36.45B(-2.0%)
Dec 2007
$37.18B(-8.7%)
$10.24B(+39.0%)
$37.18B(-0.4%)
Sep 2007
-
$7.37B(-17.9%)
$37.32B(-7.3%)
Jun 2007
-
$8.97B(-15.2%)
$40.27B(-2.4%)
Mar 2007
-
$10.59B(+1.9%)
$41.24B(+1.3%)
Dec 2006
$40.73B
$10.39B(+0.7%)
$40.73B(-0.4%)
DateAnnualQuarterlyTTM
Sep 2006
-
$10.32B(+3.7%)
$40.91B(+1.7%)
Jun 2006
-
$9.95B(-1.2%)
$40.24B(+0.7%)
Mar 2006
-
$10.08B(-4.6%)
$39.98B(-2.0%)
Dec 2005
$40.17B(-5.7%)
$10.56B(+9.5%)
$40.81B(+0.9%)
Sep 2005
-
$9.65B(-0.4%)
$40.43B(-3.7%)
Jun 2005
-
$9.69B(-11.1%)
$41.97B(-1.9%)
Mar 2005
-
$10.90B(+7.0%)
$42.80B(+0.5%)
Dec 2004
$42.60B(+21.2%)
$10.19B(-9.0%)
$42.59B(-1.2%)
Sep 2004
-
$11.19B(+6.4%)
$43.12B(+5.2%)
Jun 2004
-
$10.52B(-1.6%)
$40.99B(+6.8%)
Mar 2004
-
$10.69B(-0.2%)
$38.39B(+9.2%)
Dec 2003
$35.15B(+24.3%)
$10.72B(+18.2%)
$35.16B(+8.0%)
Sep 2003
-
$9.06B(+14.4%)
$32.55B(+6.9%)
Jun 2003
-
$7.92B(+6.2%)
$30.46B(+5.3%)
Mar 2003
-
$7.46B(-8.0%)
$28.93B(+2.3%)
Dec 2002
$28.28B(+12.2%)
$8.11B(+16.3%)
$28.28B(+9.2%)
Sep 2002
-
$6.97B(+9.0%)
$25.89B(+1.3%)
Jun 2002
-
$6.39B(-6.1%)
$25.57B(-0.6%)
Mar 2002
-
$6.81B(+18.9%)
$25.71B(+1.5%)
Dec 2001
$25.20B(+3.5%)
$5.72B(-13.9%)
$25.33B(-3.6%)
Sep 2001
-
$6.65B(+1.7%)
$26.28B(+2.8%)
Jun 2001
-
$6.54B(+1.8%)
$25.57B(+2.9%)
Mar 2001
-
$6.42B(-3.8%)
$24.84B(+1.0%)
Dec 2000
$24.35B(+7.2%)
$6.68B(+12.5%)
$24.59B(+1.8%)
Sep 2000
-
$5.94B(+2.2%)
$24.16B(+2.6%)
Jun 2000
-
$5.81B(-5.8%)
$23.53B(+1.5%)
Mar 2000
-
$6.17B(-1.1%)
$23.18B(+13.0%)
Dec 1999
$22.71B(+19.4%)
$6.24B(+17.4%)
$20.52B(-16.5%)
Sep 1999
-
$5.32B(-2.5%)
$24.57B(+10.2%)
Jun 1999
-
$5.45B(+55.4%)
$22.29B(+12.6%)
Mar 1999
-
$3.51B(-65.9%)
$19.80B(+4.2%)
Dec 1998
$19.02B(+95.9%)
$10.29B(+239.5%)
$19.00B(+67.3%)
Sep 1998
-
$3.03B(+2.4%)
$11.36B(+5.4%)
Jun 1998
-
$2.96B(+9.3%)
$10.78B(+4.1%)
Mar 1998
-
$2.71B(+2.3%)
$10.35B(+1.4%)
Dec 1997
$9.71B(+13.8%)
$2.65B(+8.1%)
$10.21B(+11.1%)
Sep 1997
-
$2.45B(-3.2%)
$9.19B(+0.8%)
Jun 1997
-
$2.53B(-1.5%)
$9.12B(+3.3%)
Mar 1997
-
$2.57B(+57.8%)
$8.83B(+3.5%)
Dec 1996
$8.53B(+3.6%)
$1.63B(-31.6%)
$8.53B(-7.1%)
Sep 1996
-
$2.38B(+6.1%)
$9.18B(+3.6%)
Jun 1996
-
$2.25B(-1.1%)
$8.86B(+3.2%)
Mar 1996
-
$2.27B(-0.6%)
$8.59B(+3.7%)
Dec 1995
$8.23B(+23.7%)
$2.28B(+10.8%)
$8.28B(+5.8%)
Sep 1995
-
$2.06B(+4.8%)
$7.83B(+5.3%)
Jun 1995
-
$1.97B(+0.1%)
$7.44B(+6.3%)
Mar 1995
-
$1.97B(+7.4%)
$7.00B(+5.2%)
Dec 1994
$6.65B(+11.6%)
$1.83B(+9.7%)
$6.65B(+3.9%)
Sep 1994
-
$1.67B(+9.2%)
$6.40B(+2.7%)
Jun 1994
-
$1.53B(-5.7%)
$6.23B(+2.5%)
Mar 1994
-
$1.62B(+2.6%)
$6.08B(+1.9%)
Dec 1993
$5.96B(+9.0%)
$1.58B(+5.4%)
$5.96B(+1.6%)
Sep 1993
-
$1.50B(+9.1%)
$5.87B(+2.2%)
Jun 1993
-
$1.37B(-8.7%)
$5.74B(+2.0%)
Mar 1993
-
$1.51B(+1.1%)
$5.63B(+3.0%)
Dec 1992
$5.47B(+9.5%)
$1.49B(+8.5%)
$5.47B(+3.7%)
Sep 1992
-
$1.37B(+8.6%)
$5.27B(+1.6%)
Jun 1992
-
$1.26B(-5.7%)
$5.19B(+1.8%)
Mar 1992
-
$1.34B(+3.4%)
$5.10B(+2.2%)
Dec 1991
$4.99B(+14.2%)
$1.30B(+0.5%)
$4.99B(+2.2%)
Sep 1991
-
$1.29B(+9.9%)
$4.88B(+3.5%)
Jun 1991
-
$1.17B(-4.6%)
$4.72B(+3.4%)
Mar 1991
-
$1.23B(+3.7%)
$4.57B(+4.4%)
Dec 1990
$4.37B(+14.5%)
$1.19B(+5.4%)
$4.37B(+37.3%)
Sep 1990
-
$1.13B(+10.6%)
$3.18B(+54.8%)
Jun 1990
-
$1.02B(-1.8%)
$2.06B(+98.2%)
Mar 1990
-
$1.04B
$1.04B
Dec 1989
$3.82B(+7.2%)
-
-
Dec 1988
$3.56B(+11.8%)
-
-
Dec 1987
$3.18B(+9.7%)
-
-
Dec 1986
$2.90B(+11.3%)
-
-
Dec 1985
$2.61B(+6.1%)
-
-
Dec 1984
$2.46B
-
-

FAQ

  • What is Pfizer annual gross profit?
  • What is the all time high annual gross profit for Pfizer?
  • What is Pfizer annual gross profit year-on-year change?
  • What is Pfizer quarterly gross profit?
  • What is the all time high quarterly gross profit for Pfizer?
  • What is Pfizer quarterly gross profit year-on-year change?
  • What is Pfizer TTM gross profit?
  • What is the all time high TTM gross profit for Pfizer?
  • What is Pfizer TTM gross profit year-on-year change?

What is Pfizer annual gross profit?

The current annual gross profit of PFE is $45.78B

What is the all time high annual gross profit for Pfizer?

Pfizer all-time high annual gross profit is $65.99B

What is Pfizer annual gross profit year-on-year change?

Over the past year, PFE annual gross profit has changed by +$12.23B (+36.47%)

What is Pfizer quarterly gross profit?

The current quarterly gross profit of PFE is $11.86B

What is the all time high quarterly gross profit for Pfizer?

Pfizer all-time high quarterly gross profit is $19.09B

What is Pfizer quarterly gross profit year-on-year change?

Over the past year, PFE quarterly gross profit has changed by $0.00 (0.00%)

What is Pfizer TTM gross profit?

The current TTM gross profit of PFE is $45.77B

What is the all time high TTM gross profit for Pfizer?

Pfizer all-time high TTM gross profit is $66.83B

What is Pfizer TTM gross profit year-on-year change?

Over the past year, PFE TTM gross profit has changed by $0.00 (0.00%)
On this page